- Author :
- Publsiher :
- Release : 01 January 1970
- ISBN :
- Pages : pages
- Rating : /5 from ratings
Preceded by Evaluation and treatment of myopathies / Robert C. Griggs, Jerry R. Mendell, Robert G. Miller. c1995.
Experimental Myopathies and Muscular Dystrophy. A Study of the Formal Pathogenesis of Primary Myopathies as Exemplified in the Myopathy of 2,4-Dichlorophenoxyacetic Acid The histochemical types of muscle fibres are described and a report presented of the histological and histochemical altera tions in skeletal muscles (tibialis anterior, gastrocnemius and soleus muscles) of rats given intraperitoneal injections of the herbicide, 2,4-dichlorophenoxyacetic acid (2,4-0). The liver and myocardium of the experimental animals were also examined. In skeletal muscle, alterations occurring acutely within 1 to 1. 5
Muscle weakness with ageing is almost inevitable, generally beginning to manifest beyond the age of 40, and is usually unstoppable. It can lead to reduced mobility, increased risk of falling, injury, and even death. But ?you?re just getting old? is not a sufficient diagnosis. Specific causes of neuromuscular symptoms may explain progressive muscle weakness, and should be investigated for potential treatment. Muscle Ageing, Inclusion-Body Myositis and Myopathies explores the clinical and pathological expression of muscle weakness in aging persons. Case
Congential myopathies, Muscular dystropies, Glycogen storage diseases of muscle, and Idiopathic and Inflammatory myopathies are presented in this volume of Neurologic Clinics. Topics include: Muscle channelopathies; Pompe disease; Congenital myopathies and muscular dystrophies; Duchenne and Becker muscular dystrophies; Distal myopathies; Limb-girdle muscular dystrophy; Fascioscapulomuneral muscular dystrophy; Myotonic dystrophy; Metabolic and mitochondrial myopathies; Sporadic inclusion body myositis; Toxic myopathies; Idiopathic Inflammatory myopathies; Approach to muscle disease.
This book presents a comprehensive review of the inflammatory myopathies, including dermatomyositis, polymyositis, and inclusion body myositis. Representing the most up-to-date knowledge on this family of diseases, this book is the gold-standard in its field.
This issue of Rheumatic Disease Clinics provides important updates in myopathies. The following essential topics are covered. Clinical features, pathophysiology, and treatment of polymyositis and dermatomyositis; inclusion body myositis; metabolic myopathies; drug-induced myopathies; muscular dystrophies and neurologic diseases; laboratory testing and imaging; electrophysiological studies; metabolic and genetic testing; and pathology.
Cardioskeletal Myopathies in Children and Young Adults focuses on plaques that kill people in their 40’s-50’s and the way they start to form in young adulthood. The Annals of Family Medicine report that approximately half of young adults have at least one cardiovascular disease risk factor (Mar 2010), and an increase in cardiovascular mortality rates in young adults was substantiated in a study at Northwestern Medicine (Nov 2011). Given the increasing recognition of genetic triggers behind all types of cardiovascular disease,
Congenital myopathies are a heterogeneous group of inherited muscle disorders, characterized by the predominance of particular histopathological features on muscle biopsy, such as cores (central core disease) or rods (nemaline myopathy). Clinically, early onset of the disease, stable or slowly progressive muscle weakness, hypotonia and delayed motor development are common in most forms. As a result, the diagnosis of a subtype of congenital myopathy is largely based on the presence of specific structural abnormalities in the skeletal muscle detected by
This book is devoted entirely to discussing the two forms of inclusion-body myositis.
Polymyositis and Dermatomyositis provides extensive information regarding Polymyositis and Dermatomyositis (PM/DM), which is described as a heterogeneous disease complex. This book is divided into four sections: Part I (Clinical Features) covers the classification of PM/DM, details of the clinical presentation, and the disease's association with the other connective tissue disorders and malignancies. Part II (Etiology and Mechanisms) covers advances in the immunopathology and viral etiology of PM/DM along with a frequently recognized entity: inclusion body myositis. Part
This practical, comprehensive and highly illustrated book will be invaluable to students and doctors of neurology and internal medicine in Africa.
One of the most puzzling and striking features of many of the genetically determined progressive neuromuscular diseases such as the spinal muscular atrophies and the muscular dystrophies is that muscular wasting and weak ness in these cases is curiously selective, at least in the early stages, pick ing out certain skeletal muscles and sparing others. The diagnosis of these conditions has largely depended in the past upon the recognition of specific patterns of involvement of individual muscles and muscle groups,
The majority of patients with myopathies have an inherited disease. Symptoms alone are not usually enough to diagnose myopathy, but they warrant further neurological examinations that are performed in larger hospitals and in special outpatient clinics for neuromuscular disorders.
The term "myositis" covers a variety of disorders often designated "idiopathic inflammatory myopathies". Although they are rather rare compared to other rheumatic diseases, they often cause severe disability and not infrequently increased mortality. The additional involvement of important internal organs such as the heart and lungs, is not uncommon. Thus, there is a great need for a better understanding of the etiopathogenesis of myositis, which may lead to improved treatment and care for these patients. Major advances regarding research and
Myopathies are a clinically and genetically heterogenous group of muscle diseases characterized by pathologic changes in muscle fibers that compromise their contractile ability. The authors of this book have gathered new research from across the globe and topics discussed in this compilation include inherited myopathies with distinct clinical manifestations; muscle biopsy as a diagnostic procedure in suspected myopathies; inflammation in dysferlinopathies; mitochondrial disorders; dysphagia in the myopathies; and aB-Crystallin (HSPB5) and myofibrillar myopathies.